Summary
The intensity of lymphoid cell infiltration and distribution of lymphocyte subsets in tumors were investigated immunohistochemically on tumor tissues obtained from 11 patients with gastric carcinoma, who had been treated with mitomycin C (MMC), 12 mg/m2, i.v. 5 days before operation. The results were compared with those obtained from 24 untreated patients as controls. In the tumor tissues from pretreated patients, the intensity of lymphoid infiltration was not significantly different from that of untreated patients. However, high-grade infiltration of CD4+ cells was observed in 55% of pretreated patients, whereas only 8% of control patients exhibited the high-grade infiltration (P <0.02). Since the CD8+ cell infiltration was not significantly altered, the ratio of CD4+ to CD8+ cells was more frequently estimated to be more than 1 in patients pretreated with MMC, as compared to untreated controls (P <0.02). Further, CD25+ cells in pretreated tumor tissues were more predominant than those in control tumor tissues (P <0.05). These results suggest that MMC administration induces these alterations in lymphocyte subsets in tumor tissue in patients with gastric carcinoma.
Similar content being viewed by others
References
Akiyoshi T, Arinaga S, Tsuji H (1987) Augmentation of the generation of cell-mediated cytotoxicity in culture by mitomycin C. Cancer Immunol Immunother 24: 259
Arinaga S, Akiyoshi T, Tsuji H (1988) Augmentation of the generation of OK-432 activated killer cells after a single dose of mitomycin C in cancer patients. Int J Immunopharmacol 10: 47
Balch CM, Railey LB, Bae Y-J, Salmeron MA, Platsoucas CD, von Eschenbach AC, Itoh K (1990) Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 126: 200
Bilik R, Mor C, Hara B, Moro C (1989) Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer. Cancer Immunol Immunother 28: 143
Cardi G, Mastrangelo MJ, Berd D (1989) Depletion of T-cells with the CD4+ CD45R; phenotype in lymphocytes that infiltrate subcutaneous metastases of human melanoma. Cancer Res 49: 6562
Finke JH, Tubbs B, Connelly B, Pontes E, Montie J (1988) Tumorinfiltrating lymphocytes in patients with renal-cell carcinoma. Ann N Y Acad Sci USA 6: 38
Japanese Research Society for Gastric Cancer (1981) The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 11: 127
Lafreniere R, Borkenhagen K, Bryant LK, Ng E (1989) Tumor-infiltrating lymphocytes cultured in recombinant interleukin-2: enhancement of growth, cytotoxicity, and phenotypic expression of cytotoxic T-cell antigens by cyclophosphamide given intravenously prior to tumor harvest. J Biol Response Mod 8: 238
Miescher S, Whiteside TL, Moretta L, Von Fiedner V (1987) Clonal and frequency analyses of tumor infiltrating T lymphocytes from human solid tumors. J Immunol 138: 4004
Nagarkatti M, Clary SR, Nagarkatti PS (1990) Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties. J Immunol 144: 4989
Nanbara S, Arinaga S, Akiyoshi T (1989) Augmentation of generation of lymphokine-activated killer cells after a single dose of mitomycin C in cancer patients. Cancer Immunol Immunother 29: 237
Ogura T, Sindo H, Shinzato O, Namba M, Masuno T, Inoue T, Kishimoto S, Yamamura Y (1982) In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats. Cancer Immunol Immunother 13: 112
Rubin JT, Elwood LJ, Rosenberg SA, Lotze MT (1989) Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans. Cancer Res 49: 7086
Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y (1986) The AMeX method: a simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 125: 431
Shimosato Y, Oboshi S, Baba K (1971) Histologic evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1: 19
Shindo H, Ogura T, Masuno T, Hayashi S, Kishimoto S (1985) Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice. Cancer Immunol Immunother 20: 145
Takagi S, Chen K, Schwarz R, Iwatsuki S, Herberman RB, Whiteside TL (1989) Functional and phenotypic analysis of tumor infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant IL 2. Cancer 63: 102
Takesue BY, Pyle JM, Mokyr MB (1990) Importance of tumor-specific cytotoxic CD8+ T-cells in eradication of a large subcutaneous MOPC-315 tumor following low-dose melphalan therapy. Cancer Res 50: 641
Topalian SL, Solomon D, Rosenberg SA (1989) Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 142: 314
Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL (1989) Characteriation of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies. J Immunol 143: 3404
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inoue, H., Adachi, M., Karimine, N. et al. Immunohistochemical analysis of lymphocyte subsets infiltrating gastric carcinoma after mitomycin C administration. Cancer Immunol Immunother 35, 297–301 (1992). https://doi.org/10.1007/BF01741141
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741141